Detalhe da pesquisa
1.
Unplanned readmissions within 30 days after discharge: improving quality through easy prediction.
Int J Qual Health Care
; 29(2): 256-261, 2017 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28453826
2.
General medical conditions in 347 bipolar disorder patients: clinical correlates of metabolic and autoimmune-allergic diseases.
J Affect Disord
; 170: 95-103, 2015 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25237732
3.
Study of the binding interaction between fluorinated matrix metalloproteinase inhibitors and Human Serum Albumin.
Eur J Med Chem
; 79: 13-23, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704692
4.
Selective arylsulfonamide inhibitors of ADAM-17: hit optimization and activity in ovarian cancer cell models.
J Med Chem
; 56(20): 8089-103, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24044434
5.
Arylsulfonamide inhibitors of aggrecanases as potential therapeutic agents for osteoarthritis: synthesis and biological evaluation.
Eur J Med Chem
; 62: 379-94, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23376997
6.
Synthesis and preliminary evaluation in tumor bearing mice of new (18)F-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.
J Med Chem
; 56(6): 2676-89, 2013 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23458498
7.
Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: a first round of lead optimization.
Eur J Med Chem
; 47(1): 143-52, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22088955
8.
Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitors.
Eur J Med Chem
; 46(7): 2617-29, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21514700
9.
Potent arylsulfonamide inhibitors of tumor necrosis factor-alpha converting enzyme able to reduce activated leukocyte cell adhesion molecule shedding in cancer cell models.
J Med Chem
; 53(6): 2622-35, 2010 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20180536
10.
Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
J Med Chem
; 52(20): 6347-61, 2009 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-19775099
11.
N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.
J Med Chem
; 52(15): 4757-73, 2009 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-19606871